000 | 01953 a2200553 4500 | ||
---|---|---|---|
005 | 20250516073947.0 | ||
264 | 0 | _c20120316 | |
008 | 201203s 0 0 eng d | ||
022 | _a1769-6917 | ||
024 | 7 |
_a10.1684/bdc.2011.1535 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLaval, Guillemette | |
245 | 0 | 0 |
_aSALTO: a randomized, multicenter study assessing octreotide LAR in inoperable bowel obstruction. _h[electronic resource] |
260 |
_bBulletin du cancer _cFeb 2012 |
||
300 |
_aE1-9 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAntiemetics _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma _xcomplications |
650 | 0 | 4 | _aDevice Removal |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDrug Therapy, Combination _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFrance |
650 | 0 | 4 |
_aGastrointestinal Agents _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntestinal Obstruction _xdrug therapy |
650 | 0 | 4 |
_aIntubation, Gastrointestinal _xinstrumentation |
650 | 0 | 4 | _aKarnofsky Performance Status |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethylprednisolone _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOctreotide _xadverse effects |
650 | 0 | 4 |
_aPeritoneal Neoplasms _xcomplications |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 |
_aVomiting _xprevention & control |
700 | 1 | _aRousselot, Hubert | |
700 | 1 | _aToussaint-Martel, Sophie | |
700 | 1 | _aMayer, Françoise | |
700 | 1 | _aTerrebonne, Eric | |
700 | 1 | _aFrançois, Eric | |
700 | 1 | _aBrixi, Hédia | |
700 | 1 | _aNguyen, Thierry | |
700 | 1 | _aBourdeix, Isabelle | |
700 | 1 | _aBisot-Locard, Ségolène | |
700 | 1 | _aZelek, Laurent | |
773 | 0 |
_tBulletin du cancer _gvol. 99 _gno. 2 _gp. E1-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1684/bdc.2011.1535 _zAvailable from publisher's website |
999 |
_c21480879 _d21480879 |